Analysts Are Bullish on These Healthcare Stocks: Medtronic (MDT), PureTech Health (PRTC)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Medtronic (MDTResearch Report) and PureTech Health (PRTCResearch Report) with bullish sentiments.

Medtronic (MDT)

In a report released today, Matt Miksic from Credit Suisse maintained a Buy rating on Medtronic, with a price target of $146.00. The company’s shares closed last Tuesday at $132.57, close to its 52-week high of $134.73.

According to TipRanks.com, Miksic is a 5-star analyst with an average return of 20.1% and a 78.0% success rate. Miksic covers the Healthcare sector, focusing on stocks such as Organogenesis Holdings, Edwards Lifesciences, and Johnson & Johnson.

Currently, the analyst consensus on Medtronic is a Strong Buy with an average price target of $146.50, a 13.8% upside from current levels. In a report issued on August 16, Deutsche Bank also maintained a Buy rating on the stock with a $149.00 price target.

See today’s analyst top recommended stocks >>

PureTech Health (PRTC)

Leerink Partners analyst Thomas Smith maintained a Buy rating on PureTech Health today and set a price target of $76.00. The company’s shares closed last Tuesday at $47.53.

According to TipRanks.com, Smith has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -18.6% and a 20.3% success rate. Smith covers the Healthcare sector, focusing on stocks such as Madrigal Pharmaceuticals, Eledon Pharmaceuticals, and CymaBay Therapeutics.

Currently, the analyst consensus on PureTech Health is a Moderate Buy with an average price target of $74.00, representing a 55.0% upside. In a report released today, Piper Sandler also maintained a Buy rating on the stock with a $72.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.